High Vista Strategies LLC Alpine Immune Sciences, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.75 - $41.6 $303,134 - $710,444	-17,078 Reduced 42.84%	22,783 $903,000
Q3 2023 Nov 14, 2023	SELL	$10.13 - $13.98 $510,815 - $704,955	-50,426 Reduced 55.85%	39,861 $456,000
Q1 2023 May 15, 2023	BUY	$7.0 - $8.75 $632,009 - $790,011	90,287 New	90,287 $697,000
Q4 2021 Feb 14, 2022	SELL	$10.41 - $13.95 $148,529 - $199,038	-14,268 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.19 - $11.31 $116,854 - $161,371	14,268 New	14,268 $152,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.